Status: Recruiting
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
This study evaluates changes in skin quality and self-esteem among breast cancer patients who are initiating aromatase inhibitor therapy.
Participants needed: 35
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Mayo ClinicUpdated: May 19, 2026Locations: 1
Eligibility criteria
* Female ≥ 18 years [+5]
* Patients who have previously taken AIs [+1]